Oculus Innovative Sciences of California received SFDA approval for Microcyn® Hydrogel, a topical treatment for moistening, repairing and healing of acute and chronic wounds. With the approval in hand, Shanghai Sunvic, the China partner of Oculus, will launch the product in Q3 of 2012, marketing Microcyn Hydrogel in both the OTC and professional healthcare markets in China. More details.... Stock Symbol: (NSDQ: OCLS) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});